Select a chapter: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 21
| Chapter 3 : Respiratory system | |
| Section | Name |
| 03.07 | Acetylcysteine |
| 03.01.02 | Aclidinium |
| 03.01.04 | Aclidinium/ Formoterol |
| 03.04.03 | Adrenaline |
| 03.04.03 | Adrenaline |
| 03.04.03 | Adrenaline |
| 03.01.03 | Aminophylline Phyllocontin Continus® |
| 03.01.03 | Aminophylline IV |
| 03.02 | Beclometasone / formoterol |
| 03.02 | Beclometasone / Formoterol / Glycopyrronium |
| 03.02 | Beclometasone Dipropionate |
| 03.04.02 | Benralizumab Fasenra® |
| 03.04.03 | Berotralstat dihydrochloride Orladeyo® |
| 03.02 | Budesonide |
| 03.02 | Budesonide / formoterol |
| 03.02 | Budesonide / Formoterol / Glycopyrronium |
| 03.04.03 | C1 Esterase Inhibitor Berinert® |
| 03.05.01 | Caffeine citrate |
| 03.07 | Carbocisteine |
| 03.07 | Carbocisteine |
| 03.04.01 | Cetirizine |
| 03.04.01 | Chlorphenamine maleate |
| 03.02 | Ciclesonide |
| 03.04.01 | Desloratadine |
| 03.07 | Dornase Alfa |
| 03.05.01 | Doxapram |
| 03.01.05 | Drug Delivery Device Volumatic® |
| 03.01.05 | Drug Delivery Device Easy Chamber® |
| 03.01.05 | Drug Delivery Device AeroChamber Plus® |
| 03.01.05 | Drug Delivery Device for paediatric use AeroChamber Plus Flow-Vu® |
| 03.07 | Erdosteine |
| 03.04.01 | Fexofenadine |
| 03.02 | Fluticasone |
| 03.02 | Fluticasone / formoterol |
| 03.02 | Fluticasone / vilanterol |
| 03.02 | Fluticasone / Vilanterol / Umeclidinium |
| 03.02 | Fluticasone and salmeterol |
| 03.01.01.01 | Formoterol |
| 03.01.02 | Glycopyrronium Seebri breezhaler® |
| 03.01.04 | Glycopyrronium / Formoterol |
| 03.01.04 | Glycopyrronium / Indacaterol |
| 03.02 | Glycopyrronium bromide and formoterol fumarate dihydrate Bevespi Aerosphere ® |
| 03.04.02 | Grass pollen extract |
| 03.04.01 | Hydroxyzine hydrochloride |
| 03.04.03 | Icatibant |
| 03.01.02 | Ipratropium |
| 03.07 | Ivacaftor Kalydeco® |
| 03.07 | Ivacaftor–Tezacaftor–Elexacaftor Kaftrio® |
| 03.04.03 | Lanadelumab Takhzyro® |
| 03.04.01 | Levocetirizine |
| 03.04.01 | Loratadine |
| 03.01.05 | Low range peak flow meter Mini-Wright® |
| 03.07 | Lumacaftor–Ivacaftor Orkambi® |
| 03.07 | Mannitol Bronchitol ® |
| 03.04.02 | Mepolizumab |
| 03.04.02 | Mepolizumab |
| 03.04.02 | Mepolizumab |
| 03.04.02 | Mepolizumab |
| 03.02 | Mometasone Asmanex® |
| 03.02 | Mometasone / Indacaterol |
| 03.02 | Mometasone / Indacaterol / Glycopyrronium |
| 03.03.02 | Montelukast |
| 03.11 | Nintedanib |
| 03.01.01.01 | Olodaterol Striverdi Respimat® |
| 03.04.02 | Omalizumab |
| 03.04.02 | Omalizumab |
| 03.04.02 | Palforzia |
| 03.11 | Pirfenidone |
| 03.05.02 | Poractant Alfa Curosurf® |
| 03.04.01 | Promethazine Phenergan® |
| 03.04.02 | Reslizumab |
| 03.03.03 | Roflumilast Daxas® |
| 03.01.01.01 | Salbutamol |
| 03.01.01.01 | Salbutamol |
| 03.01.01.01 | Salbutamol SR tablets |
| 03.01.01.01 | Salmeterol Long acting |
| 03.01.05 | Sodium Chloride |
| 03.07 | Sodium chloride |
| 03.07 | Sodium chloride 3% (Hypertonic) MucoClear® |
| 03.07 | Sodium chloride 7% (Hypertonic) Respease® |
| 03.01.05 | Standard range peak flow meter Mini-Wright® |
| 03.01.01.01 | Terbutaline |
| 03.07 | Tezacaftor–Ivacaftor Symkevi® |
| 03.04.02 | Tezepelumab |
| 03.01.03 | Theophylline |
| 03.01.02 | Tiotropium |
| 03.01.02 | Tiotropium |
| 03.01.04 | Tiotropium bromide / Olodaterol |
| 03.01.02 | Umeclidinium Incruse Ellipta® |
| 03.01.04 | Umeclidinium bromide / Vilanterol |